Luminate Medical
Ireland - GalwayBiotechnology
Focus: Luminate Medical is a public biotech company developing medical devices for chemotherapy-induced side effects, including hair loss and peripheral neuropathy. With 51-200 employees based in Galway, Ireland, it operates in a specialized neurology-focused device segment.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
10+5 this month
Growing — net +5 jobs in 30d
6 jobs added vs 1 removed. Steady team buildout.
Should You Work at Luminate Medical?
AI assessmentLuminate Medical offers early-stage device innovation upside in oncology with public-company transparency, but career stability depends on trial progression and capital availability.
Why Work Here
- Early-stage device company with two active clinical programs addressing unmet oncology needs (chemotherapy-induced alopecia and peripheral neuropathy).
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Lily Device
Chemotherapy Induced AlopeciaClinical Trials (1)
NCT06786078The Lily Device Trial
N/AHelp build intelligence for Luminate Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.